PWC News
Thursday, July 3, 2025
No Result
View All Result
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis
No Result
View All Result
PWC News
No Result
View All Result

Israeli startup Lembas unveils food additive for slimming

Home Business
Share on FacebookShare on Twitter


Israeli foodtech startup Lembas has emerged from stealth and reported that it has developed GLP-1 Edge, a bioactive peptide that triggers the manufacturing of GLP-1 and different intestine hormones that regulate urge for food and metabolism. GLP-1 is the premise for Ozempic. The corporate plans providing GLP-1 Edge as a capsule in addition to integrating it into meals as a form of “slimming meals.”

The corporate additionally introduced that it has raised $3.6 million in a pre-seed financing spherical led by FLORA Ventures, with participation from Bluestein Ventures, Recent Fund, Longevity Enterprise Companions, Maia Ventures, Siddhi Capital, Mandi Ventures and SDH.

Lembas was based in 2024 by Shay Hilel (CEO), Dr. Zohar Barbash (CTO), Prof. Maayan Gal (CSO) and Dr. Daniel Bar as a startup for the invention of meals components that may have a big well being influence utilizing AI, and the present product is its first.

GLP-1 is secreted by the physique naturally, following the consumption of sure meals, resembling meals excessive in fiber or protein. Injectable GLP-1 medication include a lot greater doses of the substance than the physique secretes by itself. Lembas’ aim was to seek out these particular meals components that may result in excessive secretion of GLP-1.

GLP-1 medication resembling Ozempic, Mounjaro and others out there below improvement, are given by injection of a hard and fast dose over a really long run. These medication result in a mean weight lack of about 15%, which is at the moment the minimal threshold for competitors within the weight reduction injection market.

There are oral medication that obtain decrease weight reduction charges, and are additionally thought-about main rivals resulting from their extra handy type of administration.

Lembas doesn’t see its product as a direct competitor to injectable drugs, however fairly as a product appropriate for individuals who don’t want to inject medication or who need to cease utilizing the treatment and are involved about gaining weight. The advice can be to interchange one meal a day with a capsule, or with meals with the complement.

It’s tough to match the effectiveness of medicines with the effectiveness of such a product, as a result of regulation doesn’t require efficacy testing in meals merchandise, and Lembas doesn’t intend to conduct an efficacy trial in people, however solely a security trial as required for meals merchandise. In animal fashions, the corporate manages to realize about two-thirds of the burden loss obtained with “semaglutide”, the energetic ingredient in Ozempic.




RELATED ARTICLES




FDA approval boosts weight reduction capsule co Epitomee


Epitomee slumps as Nestle nixes advertising and marketing weight reduction capsule






Lembas hopes its merchandise will likely be available on the market in 2027, though this depends upon agreements with meals and complement firms. Israeli firm Epitomee, which developed a weight reduction capsule with a special mechanism, signed an settlement with Nestle, which subsequently canceled the settlement after a medical trial of the product didn’t obtain the efficiency degree desired by Nestle. Lembas will face related challenges in the case of convincing meals firms that its product has a spot within the quickly growing world of GLP.

Revealed by Globes, Israel enterprise information – en.globes.co.il – on June 22, 2025.

© Copyright of Globes Writer Itonut (1983) Ltd., 2025.




Source link

Tags: additivefoodIsraeliLembasslimmingStartupUnveils
Previous Post

Mithai flavoured with artisanal chic

Next Post

Strait Of Hormuz Closure: India Exposed To Potential Fallout; Authorities Tracking Oil Trends, Say Sources

Related Posts

Bajaj Housing Finance Q1 Updates: AUM Rises 24%, Loan Assets Grow
Business

Bajaj Housing Finance Q1 Updates: AUM Rises 24%, Loan Assets Grow

July 3, 2025
Nykaa shares fall 5% after Banga family offload 2.1% stake in bulk deal
Business

Nykaa shares fall 5% after Banga family offload 2.1% stake in bulk deal

July 3, 2025
Microsoft lays off 9,000 in AI drive, bringing total job cuts to 15,000 this year
Business

Microsoft lays off 9,000 in AI drive, bringing total job cuts to 15,000 this year

July 2, 2025
Tesla shares jump 4% as investors discount EV maker’s lower than estimated Q2 deliveries
Business

Tesla shares jump 4% as investors discount EV maker’s lower than estimated Q2 deliveries

July 2, 2025
XEQT ETF: A Simple Way To Invest In Global Equities (TSX:XEQT:CA)
Business

XEQT ETF: A Simple Way To Invest In Global Equities (TSX:XEQT:CA)

July 2, 2025
Stocks to Track: Asian Paints, Grasim, Lupin, Paras Defence, MOIL, other scrips to be in focus on July 2
Business

Stocks to Track: Asian Paints, Grasim, Lupin, Paras Defence, MOIL, other scrips to be in focus on July 2

July 2, 2025
Next Post
Strait Of Hormuz Closure: India Exposed To Potential Fallout; Authorities Tracking Oil Trends, Say Sources

Strait Of Hormuz Closure: India Exposed To Potential Fallout; Authorities Tracking Oil Trends, Say Sources

Stocks to Track on Monday: TCS, BEL, Waaree Energies, HUL, HDFC Bank, Granules, Dalmia Bharat & more

Stocks to Track on Monday: TCS, BEL, Waaree Energies, HUL, HDFC Bank, Granules, Dalmia Bharat & more

Why American News Is So Jarring – 2GreenEnergy.com

Why American News Is So Jarring – 2GreenEnergy.com

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

Why BigBear.ai Could Rally 100% and Catch Palantir Soon | Investing.com
Market Analysis

Why BigBear.ai Could Rally 100% and Catch Palantir Soon | Investing.com

by PWC
July 1, 2025
0

Each investor is acquainted with one of the crucial profitable and extensively adopted tales out there as we speak, significantly...

Redstone Report: RWA Market Caps B With 85% YoY Growth as Tokenization Goes Mainstream – Crypto News Bitcoin News

Redstone Report: RWA Market Caps $24B With 85% YoY Growth as Tokenization Goes Mainstream – Crypto News Bitcoin News

June 28, 2025
Hospitals in Trouble: A Financial Playbook for Leaders and Investors

Hospitals in Trouble: A Financial Playbook for Leaders and Investors

July 1, 2025
Southern Resident Orcas Observed Grooming Each Other With Seaweed in First Documented Tool-Making by a Marine Mammal – EcoWatch

Southern Resident Orcas Observed Grooming Each Other With Seaweed in First Documented Tool-Making by a Marine Mammal – EcoWatch

June 27, 2025
5 Undervalued Tech Gems to Buy and Hold for H2 2025 | Investing.com

5 Undervalued Tech Gems to Buy and Hold for H2 2025 | Investing.com

July 3, 2025
Companies, Investors Campaign to Keep Meaningful EU Sustainability Reporting and Due Diligence Requirements – ESG Today

Companies, Investors Campaign to Keep Meaningful EU Sustainability Reporting and Due Diligence Requirements – ESG Today

July 1, 2025
PWC News

Copyright © 2024 PWC.

Your Trusted Source for ESG, Corporate, and Financial Insights

  • About Us
  • Advertise with Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact Us

Follow Us

No Result
View All Result
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis

Copyright © 2024 PWC.